Skip to main content

Table 2 Contribution of individual TNF-α and LT-α gene polymorphisms in CF lung disease progression

From: TNF gene polymorphisms in cystic fibrosis patients: contribution to the disease progression

TNF genes

FVC

p*

FEV1

p*

TNF-α-308GALT-α + 252AA

96.9 ± 9.5 (n = 12)

 

91.5 ± 10.4 (n = 12)

 

TNF-α-308GGLT-α + 252AA

78.8 ± 2.6 (n = 94)

0.025

70.3 ± 2.8 (n = 94)

0.015

TNF-α-308GALT-α + 252AG

72.5 ± 4.2 (n = 27)

0.008

66.4 ± 5.5 (n = 27)

0.009

TNF-α-308GGLT-α + 252AG

78.1 ± 3.8 (n = 33)

0.025

72.6 ± 4.6 (n = 32)

0.027

TNF-α-308GGLT-α + 252GG together with

TNF-α-308GALT-α + 252GG

76.1 ± 6.8 (n = 11)

0.029

69.3 ± 8.9 (n = 11)

0.039

  1. Boldface shows the favorable genotype in term of CF lung disease progression.
  2. FVC, forced vital capacity; FEV1, forced expiratory volume in 1 sec.
  3. * comparison with TNF-α-308GALT-α + 252AA genotype.